VerImmune

Germantown, MD · Founded 2019 · Privately Held (backing)

Developer of a virus-inspired therapeutic delivery platform designed to leverage the natural geometric structure of viruses for targeted payload transport. VerImmune is based in Germantown, MD and was founded in 2019. It was valued at $30 million at its later-stage round in Jul 2025, the last priced event on record. It has raised $10 million across 2 recorded rounds; the latest was a $4.5 million seed round in Aug 2024.

PMV mark · valuation
$30.0M
Oct 2026
Priced at
its later-stage round
Jul 2025
Total raised
$10.0M
Last round
Seed Round
Aug 2024

Who backs VerImmune?

12 investors
InvestorType
US National Science FoundationOther
Mana VenturesVenture capital
GaingelsVenture capital
TEDCOVenture capital
Ulu VenturesVenture capital
Proxima Ventures (China)Venture capital
SeedFolioVenture capital
Symbiotic VenturesVenture capital
Bailey Biofund—
John Ballantyne—
+ 2 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

VerImmune investors

12 investors are on record for VerImmune, including US National Science Foundation, Mana Ventures, Gaingels and TEDCO. By type, the record holds 7 venture capital firms. The seed round in Aug 2024 drew 6 investors.

Free account
More of VerImmune with a free account
  • ·The complete investor list: 12 names
  • ·Watch VerImmune: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 12 firms already write checks for companies like VerImmune. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View